オプション
AIプロンプト一覧 医療健康 糖尿病患者の在宅食事プラン作成

糖尿病患者の在宅食事プラン作成

{:__('collect %s',糖尿病患者の在宅食事プラン作成)}

糖尿病患者の身長体重、活動量、血糖コントロール状況に基づき、一週間の在宅1日3食の食事プランを作成し、炭水化物量と血糖上昇注意点を記載します。

プロンプト内容 コピー コピー

Based on a user-provided type 2 diabetes patient's height, weight, daily activity level, current fasting and postprandial blood sugar control status and personal dietary preferences, create a one-week three-meal daily home diet plan that fits Chinese household eating habits, mark the approximate carbohydrate content for each meal and add glycemic-related notes for dietary matching, all content complies with the mainstream guidance of Chinese nutrition community on diabetic diet.

コピー コピー

利用者が提供する2型糖尿病患者の身長・体重、日常の活動量、現在の空腹時・食後血糖コントロール状況、日常の食事嗜好に基づき、中国家庭の食習慣に合った一週間分の在宅1日3食の食事プランを作成し、各食事のおおよその炭水化物含有量と食事配合における血糖上昇関連の注意点を明記し、すべての内容は中国栄養学界における糖尿病食事に関する主流の指導規範に準拠しています。

コピー コピー
コメント (0)
0/300

おすすめ

処方箋審査アシスタント
Act as a senior clinical pharmacist to conduct a deep compliance review of the provided patient prescription data. First, extract the patient's age, gender, weight, liver and kidney function indicators, and current medication list. Second, based on the latest clinical guidelines, analyze the interaction risks between newly prescribed drugs and existing medications, focusing on contraindications, dosage limits, and administration route appropriateness. Finally, if any potential risks are identified, clearly specify the conflict points and provide evidence-based alternative solutions or adjustment recommendations to ensure the output is clear, professional, and directly supports clinical decision-making.
処方審査アシスタント
Act as a senior clinical pharmacist to review the provided patient prescription for compliance. Focus on analyzing drug-drug interactions, contraindications, and dosage appropriateness. Reference the latest clinical guidelines to identify potential risks and output a structured report including risk level, specific rationale, and adjustment recommendations to ensure patient medication safety.
処方箋審査アシスタント
Act as a senior clinical pharmacist to review the provided patient prescription. First, extract patient demographics, diagnosis, and all medication lists including dosage, frequency, and route. Second, based on the latest clinical guidelines and package inserts, check for drug-drug interactions, contraindications, and dosage adjustments for special populations such as those with hepatic or renal impairment. Focus on identifying potential drug-disease interactions and therapeutic duplication. Finally, output the audit results in a structured format, clearly flagging high-risk items and providing specific adjustment suggestions or alternative therapies to ensure medication safety and efficacy.
処方箋審査アシスタント
Act as a senior clinical pharmacist and review the provided patient prescription for compliance. Focus on analyzing drug-drug interactions, potential contraindications, and dosage appropriateness. Identify any risk points according to the latest clinical guidelines, and finally provide a clear audit conclusion with adjustment recommendations to ensure patient medication safety.
処方箋審査アシスタント
Act as a senior clinical pharmacist. Based on the provided patient demographics, medical history, and the list of medications to be prescribed, perform a prescription appropriateness review. Focus on analyzing drug-drug interactions, dosage appropriateness, and contraindications. Provide clear safety recommendations or adjustment plans based on the latest clinical guidelines to ensure patient medication safety.
処方審査アシスタント
Act as a senior clinical pharmacist and review the following prescription according to the latest clinical medication guidelines: The patient is a 65-year-old male diagnosed with type 2 diabetes and mild renal insufficiency (eGFR 45ml/min). The current prescription includes metformin, glimepiride, and aspirin. Focus on evaluating the necessity of dose adjustment for metformin in the context of renal insufficiency, analyze the hypoglycemia risk associated with glimepiride, and check for potential interactions between aspirin and anticoagulants. Finally, provide specific dosage adjustment recommendations or alternative drug suggestions to ensure the safety and efficacy of the medication regimen.
OR